v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Operating activities:      
Net income $ 251,566 $ 237,065 $ 136,777
Loss (income) from discontinued operations 15,809 (4,388) 936
Income from continuing operations 267,375 232,677 137,713
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation 41,216 41,590 25,947
Amortization and impairments to operating lease assets 27,946 32,543 32,641
Depreciation 43,850 40,702 39,676
Amortization of acquired intangible assets 11,220 11,220 35,644
Amortization and write-off of debt discount and issuance costs 7,621 5,985 5,663
Provision for credit losses 68,765 63,237 53,175
Deferred income taxes 68,352 18,413 11,073
Loss on disposals and impairments of property and equipment 743 2,527 466
Gain on investments (1,720) (1,074) (1,365)
Loss on assets held for sale   490 647
Changes in assets and liabilities:      
Accounts and financing receivables (89,263) (80,820) (76,355)
Prepaid expenses and other current assets 8,423 5,546 (8,781)
Cloud computing implementation assets (13,954) (32,823) (27,154)
Accounts payable 6,192 140 18,330
Accrued payroll and benefits 2,494 5,144 19,422
Accrued liabilities (9,697) (15,948) 27,422
Deferred revenue 50,925 34,273 40,622
Operating lease liabilities (19,802) (24,792) (36,692)
Other assets and liabilities 110 (5,296) (9,727)
Net cash provided by operating activities-continuing operations 470,796 333,734 288,367
Net cash provided by operating activities-discontinued operations (374) 4,165 7,408
Net cash provided by operating activities 470,422 337,899 295,775
Investing activities:      
Capital expenditures (77,696) (50,327) (48,893)
Proceeds from sales of marketable securities 3,260 3,120 1,732
Purchases of marketable securities (4,264) (2,048) (689)
Payment for investment in business (5,000)    
Proceeds from sale of assets   7,334  
Net cash used in investing activities (83,700) (41,921) (47,850)
Financing activities:      
Proceeds from exercise of stock options 131 10,027 17,089
Employee taxes paid on withholding shares (42,367) (14,200) (7,731)
Proceeds from stock issued under Colleague Stock Purchase Plan 1,790 1,282 810
Repurchases of common stock for treasury (239,866) (213,125) (261,966)
Borrowings under long-term debt obligations 1,007,450 9,873 1,896
Repayments under long-term debt obligations (895,283) (109,873) (51,896)
Payment of debt issuance and extinguishment costs (11,987)    
Net cash used in financing activities (180,132) (316,016) (301,798)
Net increase (decrease) in cash, cash equivalents and restricted cash 206,590 (20,038) (53,873)
Cash, cash equivalents and restricted cash at beginning of period 201,164 221,202 275,075
Cash, cash equivalents and restricted cash at end of period 407,754 201,164 221,202
Supplemental cash flow disclosure:      
Interest paid 44,841 46,596 57,842
Income taxes paid, net 13,649 32,777 31,475
Non-cash investing and financing activities:      
Accrued capital expenditures 22,642 9,226 8,718
Accrued excise tax on share repurchases $ 1,739 $ 1,630 $ 3,338